AxoGen Touts Post-BLA Growth Plan, 75%+ Gross Margin Outlook at J.P. Morgan Healthcare Conference [Yahoo! Finance]
Axogen, Inc. (AXGN)
Last axogen, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axogeninc.com
Company Research
Source: Yahoo! Finance
Management targets 15% to 20% annual growth and expects the business to be a “75% plus gross margin” company post-BLA; AxoGen is currently cash-flow positive and can fund its strategic plan from operations. Reimbursement progress and a new CMS outpatient code effective January 1 should boost adoption—AxoGen added ~ 20 million covered lives though ~ of commercial lives remain uncovered—and the company is awaiting prostate trial signals from 100 patients with results expected in H2 2026 Interested in AxoGen, Inc.? Here are five stocks we like better. AxoGen (NASDAQ:AXGN) outlined its strategy to expand peripheral nerve repair adoption and improve profitability following the company's recent biologics milestone, as executives presented at a J.P. Morgan healthcare event. President and CEO Mike Dale said AxoGen's purpose is to “restore peripheral nerve function,” positioning the company's products and education efforts as a means to make nerve repair an “expectation” in clinical c
Show less
Read more
Impact Snapshot
Event Time:
AXGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXGN alerts
High impacting Axogen, Inc. news events
Weekly update
A roundup of the hottest topics
AXGN
News
- Axogen CEO Axed 25,000 Shares From His Direct Holdings [Yahoo! Finance]Yahoo! Finance
- Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025 [Yahoo! Finance]Yahoo! Finance
- Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025GlobeNewswire
- Should You Think About Buying Axogen, Inc. (NASDAQ:AXGN) Now? [Yahoo! Finance]Yahoo! Finance
- Are Investors Undervaluing Axogen, Inc. (NASDAQ:AXGN) By 31%? [Yahoo! Finance]Yahoo! Finance
AXGN
Earnings
- 10/29/25 - Beat
AXGN
Sec Filings
- 1/12/26 - Form 8-K
- 12/17/25 - Form 4
- 12/17/25 - Form 4
- AXGN's page on the SEC website